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Abstract
Study objectives: Nonspecific interstitial pneumonia (NSIP) has been identified as a distinct entity
with a more favorable prognosis and better response to immunosuppressive therapies than usual
interstitial pneumonia (UIP). However the inflammatory profile of NSIP has not been characterized.
Design: Using immunohistochemistry techniques on open lung biopsy specimens, the infiltrate in
NSIP was characterized in terms of T and B cells, and macrophages, and the T cell population
further identified as either CD4 (helper) or CD8 (suppressor-cytotoxic) T cells. The extent of Th1
and Th2 cytokine producing cells was determined and compared to specimens from patients with
UIP.
Results: In ten NSIP tissue samples 41.4 ± 4% of mononuclear cells expressed CD3, 24.7 ± 1.8%
CD4, 19.1 ± 2% CD8, 27.4 ± 3.9% CD20, and 14.3 ± 1.6% had CD68 expression. Mononuclear
cells expressed INFγ 21.9 ± 1.9% of the time and IL-4 in 3.0 ± 1%. In contrast, biopsies from eight
patients with UIP demonstrated substantially less cellular staining for either cytokine (INFγ; 4.6 ±
1.7% and IL-4; 0.6 ± 0.3%). Significant populations of CD20 positive B-cells were also identified.
Conclusion: The lymphocytic infiltrate in NSIP is characterized by an elevated CD4/CD8 T-cell
ratio, and is predominantly of Th1 type, with additional populations rich in B-cells. Such features
are consistent with the favorable clinical course observed in patients with NSIP compared to UIP.
Introduction
Nonspecific interstitial pneumonia (NSIP) has recently
been identified as a distinct form of idiopathic interstitial
pneumonia, distinguishable from usual interstitial pneu-
monia (UIP). NSIP has been associated with better
response to immunosuppressive therapies and a more
favorable prognosis [1-4]. Histological examination dem-
onstrates that NSIP is characterized by a mononuclear
lymphocytic interstitial infiltrate, with occasional foci of
fibroblasts and variable collagen deposition [3,5]. How-
ever, the prevalence of B and T cell populations in NSIP,
and specifically the CD4 or CD8 T cell content has not
been fully defined in this disorder. Moreover, the relative
Th1 or Th2 cytokine expression associated with this dis-
ease is also not yet known.
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Inflammatory responses are generally categorized into
two major types on the basis of the predominant
cytokines secreted. Most autoimmune diseases, including
pulmonary diseases such as sarcoidosis, follow a Th1 pat-
tern, whereas allergic diseases such as asthma generally
demonstrate a Th2 pattern [6,7]. The relevance of pat-
terned cytokine expression during pulmonary fibrosis has
been supported by a number of studies [8-11]. For
instance, Th1 cells produce predominantly interferon
gamma (IFNγ) and interleukin 2 (IL-2), which impair
fibroblast activation and proliferation and suppress colla-
gen production. In contrast, Th2 cells secrete IL-4, IL-10,
and IL-13. Th2 cells may thereby act to stimulate fibrob-
last growth and promote collagen production. Thus, the
relative extent of Th1 and Th2 cytokine production may
underlie the tendency of various interstitial lung diseases
toward more or less rapid progression, and may further
limit the extent of reversibility in these disorders.
Accordingly, the following study was performed to deter-
mine the cellular populations present in lung tissue from
patients with NSIP. We first characterized the infiltrate in
NSIP in terms of T and B cells, and macrophages, and fur-
ther identified the T cell population as either CD4
(helper) or CD8 (suppressor-cytotoxic) T cells. This was
undertaken utilizing immunohistochemistry on tissues
obtained by open lung biopsy. As a second aim, we deter-
mined the extent of Th1 and Th2 cytokine producing cells
in lung tissues obtained from these patients with NSIP. In
comparison lung tissues from patients with UIP were ana-
lyzed concurrently.
Materials and methods
Subjects and Tissue Collection
The Mayo Foundation Institutional Review Board
approved these studies. All biopsies were obtained during
the routine clinical care of these patients. The study popu-
lation consisted of ten patients with a pathologic confir-
mation of NSIP established by experienced pulmonary
pathologists. The diagnosis was based on histological
findings in biopsies obtained by video assisted thoracos-
copy, between November 1997 and present according to
previously published criteria [3,12]. There were seven
women and three men in our study population, with a
mean age of 50.5 years (range 17–66) (Table 1). Three
were prior smokers and seven were never smokers. All
except one patient, had moderate to severe inflammation
present on the biopsy. In case number 1, the inflamma-
tion was judged as mild to moderate. One patient was
receiving high dose intravenous methylprednisolone at
the time of biopsy (case 5), and two were receiving oral
prednisone. Three additional patients had received pred-
nisone within the six months prior to biopsy (Table 1). In
preliminary studies, tonsillar tissue was used as a lym-
phocyte-rich control to confirm that the immunohisto-
chemical procedures employed were robust in their ability
to detect the specified cellular antigens. For comparison of
Th1 (IFNγ and Th2 (IL-4) cytokine expression, samples
from a group of patients with UIP were studied in parallel.
This population consisted of eight patients with a clinico-
pathologic diagnosis of UIP and a mean age of 65.6 years
(range 60–81). Four were prior smokers and four had
never smoked. These UIP patients were previously
reported as part of a separate, strictly morphological,
study [1].
Immunohistochemical Evaluation
Formalin-fixed, paraffin embedded sections of 5-µm
thickness were deparaffinized through three, 20 minute,
exchanges of xylene. The tissues were then rehydrated
using a graded series of alcohol washes (100%, 100%,
95%, 70%, 50% and 30%), and then incubated for 30
minutes in 0.5% hydrogen peroxide to quench endog-
enous peroxidase activity. After 30-minute incubation
with blocking serum (1% horse serum for mouse primary
antibodies and 1% goat serum for rabbit antibodies), the
primary antibodies were applied. All primary antibodies
were mouse monoclonal antibodies, with the exception of
Table 1: NSIP Patient Characteristics
Case Age Sex Background Illnesses Steroids prior to Biopsy CD4/CD8 Lymphoid Aggregates* INFγ %I L - 4  %
1 50 F - - 1.9 - 24.5 1
2 66 F - Previous 1.1 ++ 19.8 8.2
3 66 M - Current 1.5 - 14 3.9
4 51 M - - 1.1 + 17.3 -
5 17 F ARF† Current 2.1 ++ 20.7 4.8
6 45 F Current 0.8 + 12.8 1.1
7 65 F Nitrofurantoin exposure Previous 0.9 ++ 26 0.5
85 7 F - - 1 . 5 + + 2 5 . 5 2 . 4
9 31 M - Previous 1.5 ++ 28.1 7.2
10 57 F CREST - 1.2 ++ 30 0.7
• Lymphoid aggregates, + = small aggregates, ++ large aggregates, - more fibrotic
• † = acute respiratory failure present clinically prior to biopsy.Respiratory Research 2005, 6:137 http://respiratory-research.com/content/6/1/137
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Immunohistochemical localization of CD3, CD4, CD8, CD20 and CD68 in lung tissue with NSIP Figure 1
Immunohistochemical localization of CD3, CD4, CD8, CD20 and CD68 in lung tissue with NSIP. Bound primary 
antibodies to these antigens were detected by an avidin-biotin immunoperoxidase method, with AEC substrate (arrow) and 
counterstained with 1% hematoxylin. Staining for CD3 was present on lymphocytes located throughout the interstitium and 
lymphoid follicles. CD4 cells were primarily present in a perifollicular location. CD8 expressing cells were scattered through-
out the interstitium. CD20 was also primarily localized to the follicles. The CD68 macrophage/monocyte marker was found in 
clusters of the intra-alveolar spaces and on occasional individual cells within the interstitium. A. Percentage of cells stained with 
each individual antibody, expressed as a percentage of mononuclear cells within the interstitium. Values are reported as mean 
± SEM (N = 10 patients).Respiratory Research 2005, 6:137 http://respiratory-research.com/content/6/1/137
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a CD3 rabbit polyclonal antibody. The primary antibod-
ies evaluated were those recognizing CD3 (5 µg/ml,
DAKO Corporation, Carpinteria, CA), CD4 (41 µg/ml,
Novocastra Laboratories, Newcastle upon Tyne, UK), CD8
(1 µg/ml Serotec, Raleigh, NC), CD20 (8 µg/ml, DAKO) a
B cell marker, CD68 (used undiluted, DAKO) a mono-
cyte/macrophage marker, IL-4 (15 µg/ml, Stem Cell Tech-
nologies, Vancouver, BC), and INFγ (2.5 µg/ml, Stem Cell
Technologies) [13]. Antibody dilutions were applied uni-
formly in parallel across all tissues studied. Enzymatic pre-
treatment for antigen retrieval was necessary for the
detection of CD3 and INFγ, using Proteinase K (20 µg/ml
for 10 minutes at room temperature, Invitrogen Corpora-
tion, Carlsbad, CA), and IL-4, using Protease XXV (1000
µg/ml for 10 minutes at 37°C, NeoMarkers, Fremont,
CA). Heat retrieval of epitopes by boiling was used for the
CD4 and CD8 studies in the presence of 1 mM EDTA; pH
8 for 10 minutes (Sigma, St Louis, MO), and in the case of
CD20, utilizing 10 mM sodium citrate buffer; pH 6 for 10
minutes (Sigma). Primary antibody binding was detected
using the avidin-biotin immunoperoxidase method
(Vectastain Elite ABC Kit, Vector Laboratories, Burlin-
game, CA) with 3-amino-9-ethyl-carbazole substrate
(AEC) as the colorimetric substrate, producing a red to
brown pigment. The sections were counterstained with
1% hematoxylin. The percentage of positively stained cells
in each sample was determined by counting stained and
non-stained mononuclear cells in 5 randomly selected
contiguous high-power fields (400× magnification).
Fibroblasts, epithelial, endothelial cells and intravascular
cells were excluded in the enumeration procedure [14].
The coefficient of variation (standard deviation/mean ×
100%) of the enumeration procedure was ~17% on
repeated counting of the same stained sections.
Statistical analysis
Descriptive analyses were performed using the statistical
software package, JMP version 4.0 (SAS Institute Inc.,
NC). Results are expressed as mean ± standard error of the
mean. Differences between non-parametric groups were
analyzed using Wilcoxon/Kruskal-Wallis tests. P < 0.05
was considered a statistically significant difference. Coef-
ficients of variation were calculated from triplicate slide
counts from nine slides recounted in a random blinded
manner.
Results
The NSIP tissues were rich in mononuclear cells, with a
relatively high CD4/CD8 ratio, and a large number of B
cells. Abundant lymphoid aggregates were seen in eight of
ten specimens. Overall 41.4 ± 4.0% of interstitial mono-
nuclear cells expressed the pan T cell surface marker, CD3
(Figure 1). These cells were found scattered throughout
the interstitium and at the peripheries of lymphoid folli-
cles. In addition 24.7 ± 1.8% of the total mononuclear
cells were classified as CD4 lymphocytes (59.7% of the T
cells). CD4 cells were found primarily in circumferential
mantles around lymphoid follicles, but were also scat-
tered throughout the interstitial spaces. There was also
low grade staining of additional cells with this antibody,
which appeared morphologically to represent alveolar
macrophages. Furthermore, 19.1 ± 2.0% of the total
mononuclear cell population were classified as CD8 lym-
phocytes (46.5% of the T cells) (Figure 1). CD8 expressing
cells were found as strongly stained individual cells scat-
tered throughout the interstitium. The CD4/CD8 ratio
was 1.36 ± 0.13 (Table 1). When values from patients on
steroid treatment at the time of biopsy were excluded the
ratio was not found to be significantly different. In addi-
tion, the B cell marker CD20 was present on 27.4 ± 3.9%
of the mononuclear cells. B cells were detected as strongly
stained cells primarily within lymphoid follicles. We fur-
ther observed that 14.3 ± 1.6% of mononuclear cells dis-
played the macrophage/monocyte marker CD68. These
were localized as clusters in the airspaces and as occa-
sional individual cells within the interstitium (Figure 1).
When intra-alveolar cells were included 30.0 +/- 3.1% of
all mononuclear cells expressed the CD68 antigen.
Cytokine expression was substantially greater in NSIP
compared with UIP tissues. INFγ is a prototypic cytokine
characteristic of a Th1 type cytokine response. In these tis-
sues from with NSIP, cytoplasmic staining for IFNγ was
demonstrated in 21.9 ± 1.9% of the interstitial mononu-
clear cells (Figure 2). There was also abundant staining of
intra-alveolar macrophages and some staining of epithe-
lial cells for cell associated IFNγ. In contrast, IL-4 expres-
sion is more typical of a Th2 patterned cytokine response.
IL-4 was detected in 3.0 ± 1.0% of mononuclear cells in
subjects with NSIP. These IL-4 expressing cells were found
scattered throughout the biopsies as individual mononu-
clear cells. There was also some limited background stain-
ing of epithelial cells for IL-4. For comparison, 9 UIP
samples were also evaluated for IFNγ and IL-4 expression.
There was much less staining for either cytokine in the UIP
samples (Figure 2). In the UIP biopsies, very occasional
mononuclear cells (4.6 ± 1.7%) and only occasional epi-
thelial cells displayed any cell associated INFγ. Virtually
no cells exhibited IL-4 (0.6 ± 0.3%) in the UIP tissues eval-
uated.
Discussion
Alveolar interstitial lymphocytes are rare in normal lung
parenchyma. The presence of interstitial and alveolar lym-
phocytes in NSIP has been previously documented both
on histology and bronchoalveolar lavage (BAL)
[3,4,14,15]. This study was undertaken to further charac-
terize the inflammatory cell infiltrate in NSIP. The key
findings were; 1) The cellular infiltrate in NSIP is largely
composed of lymphocytes with a relatively high CD4/Respiratory Research 2005, 6:137 http://respiratory-research.com/content/6/1/137
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Immunohistochemical localization of cell-associated INFγ and IL-4 in NSIP and UIP lung biopsies Figure 2
Immunohistochemical localization of cell-associated INFγ and IL-4 in NSIP and UIP lung biopsies. NSIP tissue 
exhibited diffuse expression of INFγ on lymphocytes. INFγ was also associated with macrophages and epithelial cells. Few cells 
stained positive for IL-4 in NSIP lung. Both stains were also significantly less prominent in UIP. The percentage of stained cells 
was enumerated for the NISP and UIP samples. Values are reported as mean ± SEM for 10 NSIP and 8 UIP biopsies. (* Denotes 
significant differences in the extent of cellular staining, for INFγ P = 0.0005, for IL-4 p = 0.045 comparing NSIP and UIP by Wil-
coxon/Kruskal-Wallis Tests).Respiratory Research 2005, 6:137 http://respiratory-research.com/content/6/1/137
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CD8 ratio, 2) A large proportion of the mononuclear cells
express the B cell specific antigen CD20, and 3) Cytokine
expression was substantially greater in NSIP compared
with UIP tissues. This cytokine expression in NSIP was
predominantly a Th1 patterned response.
The observed CD4/CD8 cellular ratio of 1.36 ± 0.13 was
higher than expected and is higher than has been reported
in two prior studies [4,17]. One of these previous investi-
gations evaluated only BAL data, and the other studied
both BAL and histology in NSIP and pulmonary fibrosis
associated with connective tissue disease. The perifollicu-
lar locations of these cells make them less likely to be
washed from the alveoli during BAL [16,17]. In addition,
the majority of our NSIP biopsies demonstrated a high
degree of cellularity rather than fibrosis, which may have
also influenced our observations. Our finding that this
cellularity contains a large number of CD20 positive B
cells is of interest, and may suggest a new target for treat-
ment of NSIP. In patients who are not responding to tra-
ditional therapy, there may be a possible role for agents
such as rituximab, a monoclonal antibody against CD20
[18-20].
Clinically, NSIP behaves as a more inflammatory process,
with greater responsiveness to immunosuppressive ther-
apy, in distinct contrast to UIP. Our findings of cytokine-
rich infiltrates in NSIP further support these observations.
In our study, the cytokine expression pattern in NSIP
appears to be consistent with a predominant Th1
response. The dichotomy between Th1 and Th2 cells was
first demonstrated in murine CD4 T cell clones [21]. It has
since been identified in humans with chronic inflamma-
tory lesions [22-24].
IFNγ, which is secreted from Th1 cells, has been shown in
previous studies to suppress fibroblast activity in vitro and
in murine models of bleomycin induced fibrosis [6,24-
27]. Investigations have also suggested that patients with
UIP have impaired production of INFγ and that the
administration of IFNγ can alter their disease process
[10,28]. In contrast, Th2 cells secrete IL-4, which has been
implicated as a fibroblast-stimulating agent [29,30]. IL-4
has been found to be upregulated in some murine models
of fibrosis [31]. Enhanced production of IL-4 has also
been observed in pulmonary fibrosis associated with sys-
temic sclerosis, which also exhibits a lower Th2/Th1 ratio
than UIP, and further is associated with a substantially
higher level of INFγ production in tissue [9]. The level of
cell staining for IL-4 in the UIP samples in our study was
somewhat lower than has previously been reported. This
may have been influenced by the general lack of cellularity
of our UIP samples, as UIP is associated with heterogene-
ous involvement of the lung parenchyma. These previous
studies on UIP suggested a Th2 type response with very
low levels of INFγ, and higher levels of IL-4 [9,10].
Our study indicates that there is a substantial increase in
IFNγ production in NSIP when compared to both our UIP
specimens and previous publications [9,10]. This
increased level of IFNγ in NSIP, would be expected to
counteract the postulated pro-fibrotic effect of IL-4 and
may help explain the relative lack of fibrotic foci in this
form of idiopathic interstitial pneumonia.
One limitation to our study is the inclusion of patients in
the study group who were receiving glucocorticoids, or
had been treated with them in the past. This was necessary
as during this time period, at our institution, only a small
number of patients with interstitial lung disease were pro-
ceeding to surgical lung biopsy without a previous trial of
glucocorticoids. In analyzing the results, there was no sig-
nificant difference between cytokine levels based on cur-
rent or previous treatment.
In conclusion, we observed that NSIP is characterized by
a largely lymphocytic infiltrate, with a high CD4/CD8
ratio, rich in cytokines, predominantly exhibiting a Th1
type response. These findings may in part explain why
NSIP, in comparison to UIP, follows a slower, less fibrotic
course, and is more responsive to immune modulatory
therapies.
Abbreviation list
AEC = 3-amino-9-ethyl-carbazole substrate
BAL = bronchoalveolar lavage
IFNγ = interferon gamma
IL = interleukin
NSIP = Nonspecific interstitial pneumonia
UIP = usual interstitial pneumonia
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